×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ILMN – illumina, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ILMN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/5
04:22 pm
ilmn
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.
12/4
07:18 am
ilmn
Illumina (NASDAQ:ILMN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Illumina (NASDAQ:ILMN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/29
03:36 pm
ilmn
Illumina (NASDAQ:ILMN) was upgraded by analysts at Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
Low
Report
Illumina (NASDAQ:ILMN) was upgraded by analysts at Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
11/18
08:01 am
ilmn
Preimplantation Genetic Testing Market Size to Reach USD 1849.38 Million by 2032 – SNS Insider [Yahoo! Finance]
Medium
Report
Preimplantation Genetic Testing Market Size to Reach USD 1849.38 Million by 2032 – SNS Insider [Yahoo! Finance]
11/12
12:33 pm
ilmn
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study [Yahoo! Finance]
Low
Report
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study [Yahoo! Finance]
11/12
12:00 pm
ilmn
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
Low
Report
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
11/11
04:05 pm
ilmn
Illumina To Webcast Upcoming Investor Conference
Low
Report
Illumina To Webcast Upcoming Investor Conference
11/10
01:02 pm
ilmn
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks [Yahoo! Finance]
Low
Report
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/25
05:06 pm
ilmn
Form 8-K ILLUMINA, INC. For: Nov 25
Low
Report
Form 8-K ILLUMINA, INC. For: Nov 25
11/13
07:07 pm
ilmn
Form SCHEDULE 13G/A ILLUMINA, INC. Filed by: Capital World Investors
Low
Report
Form SCHEDULE 13G/A ILLUMINA, INC. Filed by: Capital World Investors
11/12
05:00 pm
ilmn
Form 8-K ILLUMINA, INC. For: Nov 10
Low
Report
Form 8-K ILLUMINA, INC. For: Nov 10
11/12
04:06 pm
ilmn
Form 144 ILLUMINA, INC. Filed by: Davies Scott M
Low
Report
Form 144 ILLUMINA, INC. Filed by: Davies Scott M
11/12
06:01 am
ilmn
Form FWP ILLUMINA, INC. Filed by: ILLUMINA, INC.
Low
Report
Form FWP ILLUMINA, INC. Filed by: ILLUMINA, INC.
11/7
04:33 pm
ilmn
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Davies Scott M
Low
Report
Form 4 ILLUMINA, INC. For: Nov 05 Filed by: Davies Scott M
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Illumina, Inc. (ILMN): Are Hedge Funds Right About This Stock? [Yahoo! Finance News]
9.2%
3/17 IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions 5.0%
4/3 Form 4 ILLUMINA, INC. For: Apr 01 Filed by: Dadswell Charles 4.5%
10/26 Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Canaccord Genuity from $300.00 to $310.00. They now have a "hold" rating on the stock. 4.5%
4/16 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19 4.2%
3/26 Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Barclays PLC from $390.00 to $350.00. They now have an "overweight" rating on the stock. 3.7%
6/28 BRIEF-Illumina Files Patent Infringement Suits Related To Bgi In Switzerland, Turkey And The Us [Reuters] 3.6%
6/3 Form 8-K ILLUMINA INC For: May 29 3.3%
3/9 Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Hoyt Aimee L 3.2%
10/8 Illumina to Announce Third Quarter 2019 Financial Results on Thursday, October 24, 2019 3.0%
3/17 IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions 5.0%
4/3 Form 4 ILLUMINA, INC. For: Apr 01 Filed by: Dadswell Charles 4.5%
10/26 Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Canaccord Genuity from $300.00 to $310.00. They now have a "hold" rating on the stock. 4.5%
4/16 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19 4.2%
3/26 Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Barclays PLC from $390.00 to $350.00. They now have an "overweight" rating on the stock. 3.7%
6/28 BRIEF-Illumina Files Patent Infringement Suits Related To Bgi In Switzerland, Turkey And The Us [Reuters] 3.6%
6/3 Form 8-K ILLUMINA INC For: May 29 3.3%
3/9 Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Hoyt Aimee L 3.2%
10/8 Illumina to Announce Third Quarter 2019 Financial Results on Thursday, October 24, 2019 3.0%
TOP News Decliners
7/11
Illumina Reports Preliminary Revenue for Second Quarter of Fiscal Year 2019
-15.3%
10/24 Form 8-K ILLUMINA, INC. For: Oct 24 -12.5%
4/30 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020 -7.3%
1/29 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 -6.6%
5/10 Form 4 ILLUMINA INC For: May 08 Filed by: FLATLEY JAY T -4.7%
10/7 Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests -4.4%
2/25 Did You Miss Illumina's (NASDAQ:ILMN) 68% Share Price Gain? [Yahoo! Finance News] -3.7%
4/20 Form 4 ILLUMINA, INC. For: Apr 16 Filed by: Van Oene Mark -3.6%
8/13 Form 4 ILLUMINA INC For: Aug 09 Filed by: OSTADAN OMEAD -3.6%
2/6 Form 4 ILLUMINA, INC. For: Feb 05 Filed by: Van Oene Mark -2.8%
10/24 Form 8-K ILLUMINA, INC. For: Oct 24 -12.5%
4/30 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020 -7.3%
1/29 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 -6.6%
5/10 Form 4 ILLUMINA INC For: May 08 Filed by: FLATLEY JAY T -4.7%
10/7 Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests -4.4%
2/25 Did You Miss Illumina's (NASDAQ:ILMN) 68% Share Price Gain? [Yahoo! Finance News] -3.7%
4/20 Form 4 ILLUMINA, INC. For: Apr 16 Filed by: Van Oene Mark -3.6%
8/13 Form 4 ILLUMINA INC For: Aug 09 Filed by: OSTADAN OMEAD -3.6%
2/6 Form 4 ILLUMINA, INC. For: Feb 05 Filed by: Van Oene Mark -2.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: